焦作市第二人民医院2017年中药注射剂使用情况点评
|
摘要
目的对焦作市第二人民医院(以下简称"本院")中药注射剂使用情况进行专项点评,为促进临床进一步合理使用中药注射剂提供参考。方法 2017年1-12月,每月从本院各科室随机抽取10份出院病历,共计3120份,对其中使用中药注射剂的病历进行合理性点评分析。结果 3120份病历中,有1193份病历使用了中药注射剂,不合理使用病历556份(46.61%)。比较突出的问题包括单次超剂量用药、溶媒选择不适宜和重复用药等。结论本院需进一步干预规范中药注射剂在临床的合理使用。
Objective To provide a reference for promoting the further rational use of TCM injections through special comments on the use of TCM injections in Jiaozuo Second People's Hospital(hereinafter referred to as "our hospital"). Methods From January to December 2017, 10 hospitalized case records were randomly selected monthly from each department of our hospital, totaling 3120 copies, and the medical records of TCM injections were evaluated for rationality. Results Among the 3120 cases, 1193 cases used TCM injections, and 556 cases(46.61%) were unreasonable. More prominent problems included single overdose medication, inappropriate solvent selection,repeated medication, etc. Conclusion Our hospital still needs further intervention to regulate the rational use of TCM injections in clinical practice.
Objective To provide a reference for promoting the further rational use of TCM injections through special comments on the use of TCM injections in Jiaozuo Second People's Hospital(hereinafter referred to as "our hospital"). Methods From January to December 2017, 10 hospitalized case records were randomly selected monthly from each department of our hospital, totaling 3120 copies, and the medical records of TCM injections were evaluated for rationality. Results Among the 3120 cases, 1193 cases used TCM injections, and 556 cases(46.61%) were unreasonable. More prominent problems included single overdose medication, inappropriate solvent selection,repeated medication, etc. Conclusion Our hospital still needs further intervention to regulate the rational use of TCM injections in clinical practice.
引文
[1]国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2015:附录13.
[2]戈长征,任贻军,张宏琳,等.21例黄芪注射液致过敏性休克文献分析[J].中医药导报,2011,17(10):88-89.
[3]杨薇,向永洋,谢雁鸣,等.舒血宁注射液临床不良反应特征及预警信号探测研究[J].中国中药杂志,2013,38(18):3013-3018.
[4]李荣,蒋英蓝,曾敬怀,等.中药注射剂发生不良反应的相关性研究进展[J].中成药,2013,35(5):1059-1061.
[5]呼梅,高群,谈静,等.中药注射液与输液配伍的稳定性研究概述[J].中国中医药信息杂志,2008,15(5):102-104.
[6]龚建华,孔凡有.丹红注射液与不同溶媒配伍时不溶性微粒及pH值的变化[J].现代诊断与治疗,2012,23(10):1674-1675.
[7]左文,李江,李婷.某院活血化瘀类中药注射剂不合理联用情况与分析[J].中国医院药学杂志,2017,37(21):2193-2196.
[8]李蓓.56例丹参川芎嗪注射液不良反应/事件分析[J].中国药物评价,2013,30(3):159-160.
[9]郑雪.4种常用中药注射液不同浓度对不溶性微粒的影响[J].中国药师,2017,20(2):374-376.
[10]张奇兵,袁琚,赵寿宁.我院干预前后中药注射剂使用合理性分析[J].中国药房,2015,26(8):1030-1032.
[11]张颖.97例中药注射剂不良反应/事件分析[J].中国药物警戒,2011,8(8):498-500.
[12]刘治军,陈頔,谭玲.基于某院2012-2014年度中药注射剂临床应用情况探讨中药注射剂的合理应用和监管[J].中国药学杂志,2015,50(18):1648-1652.
[2]戈长征,任贻军,张宏琳,等.21例黄芪注射液致过敏性休克文献分析[J].中医药导报,2011,17(10):88-89.
[3]杨薇,向永洋,谢雁鸣,等.舒血宁注射液临床不良反应特征及预警信号探测研究[J].中国中药杂志,2013,38(18):3013-3018.
[4]李荣,蒋英蓝,曾敬怀,等.中药注射剂发生不良反应的相关性研究进展[J].中成药,2013,35(5):1059-1061.
[5]呼梅,高群,谈静,等.中药注射液与输液配伍的稳定性研究概述[J].中国中医药信息杂志,2008,15(5):102-104.
[6]龚建华,孔凡有.丹红注射液与不同溶媒配伍时不溶性微粒及pH值的变化[J].现代诊断与治疗,2012,23(10):1674-1675.
[7]左文,李江,李婷.某院活血化瘀类中药注射剂不合理联用情况与分析[J].中国医院药学杂志,2017,37(21):2193-2196.
[8]李蓓.56例丹参川芎嗪注射液不良反应/事件分析[J].中国药物评价,2013,30(3):159-160.
[9]郑雪.4种常用中药注射液不同浓度对不溶性微粒的影响[J].中国药师,2017,20(2):374-376.
[10]张奇兵,袁琚,赵寿宁.我院干预前后中药注射剂使用合理性分析[J].中国药房,2015,26(8):1030-1032.
[11]张颖.97例中药注射剂不良反应/事件分析[J].中国药物警戒,2011,8(8):498-500.
[12]刘治军,陈頔,谭玲.基于某院2012-2014年度中药注射剂临床应用情况探讨中药注射剂的合理应用和监管[J].中国药学杂志,2015,50(18):1648-1652.